Chondroitin Sulfate Market by Source and End Use - Global Industry Analysis & Forecast to 2027

Published On : August 2019 Pages : 170 Category: Food and Beverages Report Code : FB084800

Chondroitin Sulfate Market By Source (Bovine, Poultry, Porcine, Fish, Shark, & Crocodile and Others) and End Use (Cosmetics & Personal Care, Aquafeed, Pharmaceuticals & Nutraceuticals and Pet Food & Veterinary Supplements) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

Chondroitin sulfate is also called sulfated glycosaminoglycan (GAG). Chondroitin sulfate is made out of a gigantic chain of rotating sugars, for example, glucuronic corrosive and N-acetylgalactosamine. Chondroitin sulfate is a substance exacerbate that is available in the connective tissues in people, which is found in the ligaments and joints of the body. Business chondroitin sulfate is made from different creature sources, for example, porcine, cow-like, poultry, fish, shark, crocodile, and different creatures.

Drivers and Restraints

The interest for chondroitin sulfate is relied upon to increment sooner rather than later at a higher rate from dietary enhancement makers, attributable to expanding social insurance consumption, populace ages, and higher accentuation of people on preventive consideration and self-administration by methods for dietary enhancements so as to keep up wellbeing and health. Moreover, the interest for chondroitin sulfate is expanding for joint wellbeing supplements with the prospering wellbeing cognizant customers and maturing populace.

Regional Insights

The increasing demand for chondroitin sulfate in multiple industries is projected to accelerate the growth of the market in the coming years in the Asia Pacific region.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • TSI Group Ltd.,
  • AcerChem International Inc.
  • Jiaxing Hengjie Biopharmaceutical Co., Ltd
  • Aoxing Biotechnology Intl Co., Limited
  • Stanford Chemicals
  • Sioux Pharm, Inc.
  • Solabia Group
  • Seikagaku Corporation
  • Aoxing Biotechnology Intl Co., Limited
  • Shanghai JBiChem International Trading Co.,Ltd.
  • Pacific Rainbow International, Inc.

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Chondroitin Sulfate Market, By Source, Estimates and Forecast, 2017-2027 ($Million)

o    Bovine

o    Poultry

o    Porcine

o    Fish

o    Shark

o    Crocodile

o    Others

·         Chondroitin Sulfate Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

o    Cosmetics & Personal Care

o    Aquafeed

o    Pharmaceuticals & Nutraceuticals

o    Pet Food & Veterinary Supplements

·         Chondroitin Sulfate Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o    TSI Group Ltd.,

o    AcerChem International Inc.

o    Jiaxing Hengjie Biopharmaceutical Co., Ltd

o    Aoxing Biotechnology Intl Co., Limited

o    Stanford Chemicals

o    Sioux Pharm, Inc.

o    Solabia Group

o    Seikagaku Corporation

o    Aoxing Biotechnology Intl Co., Limited

o    Shanghai JBiChem International Trading Co.,Ltd.

o    Pacific Rainbow International, Inc.

·         Chondroitin Sulfate Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o    North America

§  North America Chondroitin Sulfate Market, By Country

o    U.S. Chondroitin Sulfate Market

o    Canada Chondroitin Sulfate Market

o    Mexico Chondroitin Sulfate Market

o    Europe

§  Europe Chondroitin Sulfate Market, By Country

o    Germany Chondroitin Sulfate Market

o    UK Chondroitin Sulfate Market

o    France Chondroitin Sulfate Market

o    Russia Chondroitin Sulfate Market

o    Italy Chondroitin Sulfate Market

o    Rest of Europe Chondroitin Sulfate Market

o    Asia-Pacific

§  Asia-Pacific Chondroitin Sulfate Market, By Country

o    China Chondroitin Sulfate Market

o    Japan Chondroitin Sulfate Market

o    South Korea Chondroitin Sulfate Market

o    India Chondroitin Sulfate Market

o    Southeast Asia Chondroitin Sulfate Market

o    Rest of Asia-Pacific Chondroitin Sulfate Market

o    South America

§  South America Chondroitin Sulfate Market

o    Brazil Chondroitin Sulfate Market

o    Argentina Chondroitin Sulfate Market

o    Columbia Chondroitin Sulfate Market

o    Rest of South America Chondroitin Sulfate Market

o    Middle East and Africa

§  Middle East and Africa Chondroitin Sulfate Market

o    Saudi Arabia Chondroitin Sulfate Market

o    UAE Chondroitin Sulfate Market

o    Egypt Chondroitin Sulfate Market

o    Nigeria Chondroitin Sulfate Market

o    South Africa Chondroitin Sulfate Market

o    Rest of MEA Chondroitin Sulfate Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Chondroitin Sulfate Market, By Source

5.1.     Introduction

5.2.     Global Chondroitin Sulfate Revenue and Market Share by Source  (2017-2027)

5.2.1.  Global Chondroitin Sulfate Revenue and Revenue Share by Source  (2017-2027)

5.3.     Bovine

5.3.1.  Global Bovine Revenue and Growth Rate (2017-2027)

5.4.     Poultry

5.4.1.  Global Poultry Revenue and Growth Rate (2017-2027)

5.5.     Porcine

5.5.1.  Global Porcine Revenue and Growth Rate (2017-2027)

5.6.     Fish

5.6.1.  Global Fish Revenue and Growth Rate (2017-2027)

5.7.     Shark

5.7.1.  Global Shark Revenue and Growth Rate (2017-2027)

5.8.     Crocodile

5.8.1.  Global Crocodile  Revenue and Growth Rate (2017-2027)

5.9.     Other

5.9.1.  Global Other Revenue and Growth Rate (2017-2027)

6.       Chondroitin Sulfate Market, By End User

6.1.     Introduction

6.2.     Global Chondroitin Sulfate Revenue and Market Share by End User (2017-2027)

6.2.1.  Global Chondroitin Sulfate Revenue and Revenue Share by End User (2017-2027)

6.3.     Cosmetics & Personal Care

6.3.1.  Global Cosmetics & Personal Care Revenue and Growth Rate (2017-2027)

6.4.     Aquafeed

6.4.1.  Global Aquafeed Revenue and Growth Rate (2017-2027)

6.5.     Pharmaceuticals & Nutraceuticals

6.5.1.  Global Pharmaceuticals & Nutraceuticals  Revenue and Growth Rate (2017-2027)

6.6.     Pet Food & Veterinary Supplements

6.6.1.  Global Pet Food & Veterinary Supplements Revenue and Growth Rate (2017-2027)

7.       Chondroitin Sulfate Market, By Region

7.1.     Introduction

7.2.     Global Chondroitin Sulfate Revenue and Market Share by Regions

7.2.1.  Global Chondroitin Sulfate Revenue by Regions (2017-2027)

7.3.     North America Chondroitin Sulfate by Countries

7.3.1.  North America Chondroitin Sulfate Revenue and Growth Rate (2017-2027)

7.3.2.  North America Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2027)

7.3.3.  United States

7.3.3.1.  United States Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4.  Canada

7.3.4.1.  Canada Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5.  Mexico

7.3.5.1.  Mexico Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.     Europe Chondroitin Sulfate by Countries

7.4.1.  Europe Chondroitin Sulfate Revenue and Growth Rate (2017-2027)

7.4.2.  Europe Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2027)

7.4.3.  Germany

7.4.3.1.  Germany Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4.  France

7.4.4.1.  France Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5.  UK

7.4.5.1.  UK Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6.  Russia

7.4.6.1.  Russia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7.  Italy

7.4.7.1.  Italy Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.     Asia-Pacific Chondroitin Sulfate by Countries

7.5.1.  Asia-Pacific Chondroitin Sulfate Revenue and Growth Rate (2017-2027)

7.5.2.  Asia-Pacific Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2027)

7.5.3.  China

7.5.3.1.  China Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4.  Japan

7.5.4.1.  Japan Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5.  Korea

7.5.5.1.  Korea Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6.  India

7.5.6.1.  India Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.     South America Chondroitin Sulfate by Countries

7.6.1.  South America Chondroitin Sulfate Revenue and Growth Rate (2017-2027)

7.6.2.  South America Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2027)

7.6.3.  Brazil

7.6.3.1.  Brazil Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4.  Argentina

7.6.4.1.  Argentina Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5.  Columbia

7.6.5.1.  Columbia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.     Middle East and Africa Chondroitin Sulfate by Countries

7.7.1.  Middle East and Africa Chondroitin Sulfate Revenue and Growth Rate (2017-2027)

7.7.2.  Middle East and Africa Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2027)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5.  Egypt

7.7.5.1.  Egypt Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7.  South Africa

7.7.7.1.  South Africa Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8.  Turkey

7.7.8.1.  Turkey Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

8.       Company Profiles

8.1.     TSI Group Ltd.

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     AcerChem International Inc.

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Jiaxing Hengjie Biopharmaceutical Co., Ltd

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     Aoxing Biotechnology Intl Co., Limited

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Stanford Chemicals

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Sioux Pharm, Inc.

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Solabia Group

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     Seikagaku Corporation

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Aoxing Biotechnology Intl Co., Limited

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

8.10. Shanghai JBiChem International Trading Co.,Ltd.

8.10.1.      Business Overview

8.10.2.       Service Portfolio

8.10.3.      Strategic Developments

8.10.4.      Financial Overview

8.11. Pacific Rainbow International, Inc.

8.11.1.      Business Overview

8.11.2.       Service Portfolio

8.11.3.      Strategic Developments

8.11.4.      Financial Overview

9.       Chondroitin Sulfate Market Forecast (2017-2027)

9.1.     Global Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2027)

9.2.     Chondroitin Sulfate Market Forecast by Regions (2017-2027)

9.2.1.  North America Chondroitin Sulfate Market Forecast (2017-2027)

9.2.1.1.  United States Chondroitin Sulfate Market Forecast (2017-2027)

9.2.1.2.  Canada Chondroitin Sulfate Market Forecast (2017-2027)

9.2.1.3.  Mexico Chondroitin Sulfate Market Forecast (2017-2027)

9.2.2.  Europe Chondroitin Sulfate Market Forecast (2017-2027)

9.2.2.1.  Germany Chondroitin Sulfate Market Forecast (2017-2027)

9.2.2.2.  France Chondroitin Sulfate Market Forecast (2017-2027)

9.2.2.3.  UK Chondroitin Sulfate Market Forecast (2017-2027)

9.2.2.4.  Russia Chondroitin Sulfate Market Forecast (2017-2027)

9.2.2.5.  Italy Chondroitin Sulfate Market Forecast (2017-2027)

9.2.2.6.  Rest of Europe Chondroitin Sulfate Market Forecast (2017-2027)

9.2.3.  Asia-Pacific Chondroitin Sulfate Market Forecast (2017-2027)

9.2.3.1.  China Chondroitin Sulfate Market Forecast (2017-2027)

9.2.3.2.  Japan Chondroitin Sulfate Market Forecast (2017-2027)

9.2.3.3.  Korea Chondroitin Sulfate Market Forecast (2017-2027)

9.2.3.4.  India Chondroitin Sulfate Market Forecast (2017-2027)

9.2.3.5.  Southeast Asia Chondroitin Sulfate Market Forecast (2017-2027)

9.2.3.6.  Rest of Asia-Pacific Chondroitin Sulfate Market Forecast (2017-2027)

9.2.4.  South America Chondroitin Sulfate Market Forecast (2017-2027)

9.2.4.1.  Brazil Chondroitin Sulfate Market Forecast (2017-2027)

9.2.4.2.  Argentina Chondroitin Sulfate Market Forecast (2017-2027)

9.2.4.3.  Columbia Chondroitin Sulfate Market Forecast (2017-2027)

9.2.4.4.  Rest of South America Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.  Middle East and Africa Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.1.  Saudi Arabia Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.2.  United Arab Emirates Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.3.  Egypt Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.4.  Nigeria Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.5.  South Africa Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.6.  Turkey Chondroitin Sulfate Market Forecast (2017-2027)

9.2.5.7.  Rest of Middle East and Africa Chondroitin Sulfate Market Forecast (2017-2027)

9.3.     Chondroitin Sulfate Market Forecast by Source  (2017-2027)

9.3.1.  Chondroitin Sulfate Forecast by Source  (2017-2027)

9.3.2.  Chondroitin Sulfate Market Share Forecast by Source  (2017-2027)

9.4.     Chondroitin Sulfate Market Forecast by End User (2017-2027)

9.4.1.  Chondroitin Sulfate Forecast by End User (2017-2027)

9.4.2.  Chondroitin Sulfate Market Share Forecast by End User (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Chondroitin Sulfate Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Chondroitin Sulfate Revenue and Revenue Share by Source (2017-2018)
Figure Global Bovine Revenue and Growth Rate (2017-2018)
Figure Global Poultry Revenue and Growth Rate (2017-2018)
Figure Global Porcine Revenue and Growth Rate (2017-2018)
Figure Global Fish Revenue and Growth Rate (2017-2018)
Figure Global Shark Revenue and Growth Rate (2017-2018)
Figure Global Crocodile Revenue and Growth Rate (2017-2018)
Figure Global Other Revenue and Growth Rate (2017-2018)
Table Global Chondroitin Sulfate Revenue and Revenue Share by End User (2017-2018)
Figure Global Cosmetics & Personal Care Revenue and Growth Rate (2017-2018)
Figure Global Aquafeed Revenue and Growth Rate (2017-2018)
Figure Global Pharmaceuticals & Nutraceuticals Revenue and Growth Rate (2017-2018)
Figure Global Pet Food & Veterinary Supplements Revenue and Growth Rate (2017-2018)
Table Global Chondroitin Sulfate Revenue by Regions (2017-2018)
Figure North America Chondroitin Sulfate Growth Rate (2017-2018)
Figure North America Chondroitin Sulfate Revenue and Growth Rate (2017-2018)
Figure North America Chondroitin Sulfate by Countries (2017-2018)
Figure North America Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2018)
Figure United States Chondroitin Sulfate Growth Rate (2017-2018)
Figure United States Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Chondroitin Sulfate Growth Rate (2017-2018)
Figure Canada Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Chondroitin Sulfate Growth Rate (2017-2018)
Figure Mexico Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Chondroitin Sulfate Growth Rate (2017-2018)
Figure Europe Chondroitin Sulfate Revenue and Growth Rate (2017-2018)
Figure Europe Chondroitin Sulfate by Countries (2017-2018)
Figure Europe Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2018)
Figure Germany Chondroitin Sulfate Growth Rate (2017-2018)
Figure Germany Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Chondroitin Sulfate Growth Rate (2017-2018)
Figure France Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Chondroitin Sulfate Growth Rate (2017-2018)
Figure UK Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Chondroitin Sulfate Growth Rate (2017-2018)
Figure Russia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Chondroitin Sulfate Growth Rate (2017-2018)
Figure Italy Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Chondroitin Sulfate Growth Rate (2017-2018)
Figure Rest of Europe Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Chondroitin Sulfate Growth Rate (2017-2018)
Figure Asia-Pacific Chondroitin Sulfate Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Chondroitin Sulfate by Countries (2017-2018)
Figure Asia-Pacific Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2018)
Figure China Chondroitin Sulfate Growth Rate (2017-2018)
Figure China Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Chondroitin Sulfate Growth Rate (2017-2018)
Figure Japan Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Chondroitin Sulfate Growth Rate (2017-2018)
Figure Korea Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Chondroitin Sulfate Growth Rate (2017-2018)
Figure India Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Chondroitin Sulfate Growth Rate (2017-2018)
Figure Southeast Asia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Chondroitin Sulfate Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Chondroitin Sulfate Growth Rate (2017-2018)
Figure South America Chondroitin Sulfate Revenue and Growth Rate (2017-2018)
Figure South America Chondroitin Sulfate by Countries (2017-2018)
Figure South America Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Chondroitin Sulfate Growth Rate (2017-2018)
Figure Brazil Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Chondroitin Sulfate Growth Rate (2017-2018)
Figure Argentina Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Chondroitin Sulfate Growth Rate (2017-2018)
Figure Columbia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Chondroitin Sulfate Growth Rate (2017-2018)
Figure Rest of South America Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Chondroitin Sulfate Growth Rate (2017-2018)
Figure Middle East and Africa Chondroitin Sulfate Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Chondroitin Sulfate by Countries (2017-2018)
Figure Middle East and Africa Chondroitin Sulfate Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Chondroitin Sulfate Growth Rate (2017-2018)
Figure Saudi Arabia Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Chondroitin Sulfate Growth Rate (2017-2018)
Figure United Arab Emirates Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Chondroitin Sulfate Growth Rate (2017-2018)
Figure Egypt Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Chondroitin Sulfate Growth Rate (2017-2018)
Figure Nigeria Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Chondroitin Sulfate Growth Rate (2017-2018)
Figure South Africa Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Chondroitin Sulfate Growth Rate (2017-2018)
Figure Turkey Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Chondroitin Sulfate Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2017-2018)
Table TSI Group Ltd. Chondroitin Sulfate Financial Overview
Table AcerChem International Inc. Chondroitin Sulfate Financial Overview
Table Jiaxing Hengjie Biopharmaceutical Co., Ltd Chondroitin Sulfate Financial Overview
Table Aoxing Biotechnology Intl Co., Limited Chondroitin Sulfate Financial Overview
Table Stanford Chemicals Chondroitin Sulfate Financial Overview
Table Sioux Pharm, Inc. Chondroitin Sulfate Financial Overview
Table Solabia Group Chondroitin Sulfate Financial Overview
Table Seikagaku Corporation Chondroitin Sulfate Financial Overview
Table Aoxing Biotechnology Intl Co., Limited Chondroitin Sulfate Financial Overview
Table Shanghai JBiChem International Trading Co.,Ltd. Chondroitin Sulfate Financial Overview
Table Pacific Rainbow International, Inc. Chondroitin Sulfate Financial Overview
Figure Global Chondroitin Sulfate Revenue (Millions USD) and Growth Rate (2018-2025)
Table Chondroitin Sulfate Market Forecast by Regions (2018-2025)
Figure North America Chondroitin Sulfate Market Forecast (2018-2025)
Figure United States Chondroitin Sulfate Market Forecast (2018-2025)
Figure Canada Chondroitin Sulfate Market Forecast (2018-2025)
Figure Mexico Chondroitin Sulfate Market Forecast (2018-2025)
Figure Europe Chondroitin Sulfate Market Forecast (2018-2025)
Figure Germany Chondroitin Sulfate Market Forecast (2018-2025)
Figure France Chondroitin Sulfate Market Forecast (2018-2025)
Figure UK Chondroitin Sulfate Market Forecast (2018-2025)
Figure Russia Chondroitin Sulfate Market Forecast (2018-2025)
Figure Italy Chondroitin Sulfate Market Forecast (2018-2025)
Figure Rest of Europe Chondroitin Sulfate Market Forecast (2018-2025)
Figure Asia-Pacific Chondroitin Sulfate Market Forecast (2018-2025)
Figure China Chondroitin Sulfate Market Forecast (2018-2025)
Figure Japan Chondroitin Sulfate Market Forecast (2018-2025)
Figure Korea Chondroitin Sulfate Market Forecast (2018-2025)
Figure India Chondroitin Sulfate Market Forecast (2018-2025)
Figure Southeast Asia Chondroitin Sulfate Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Chondroitin Sulfate Market Forecast (2018-2025)
Figure South America Chondroitin Sulfate Market Forecast (2018-2025)
Figure Brazil Chondroitin Sulfate Market Forecast (2018-2025)
Figure Argentina Chondroitin Sulfate Market Forecast (2018-2025)
Figure Columbia Chondroitin Sulfate Market Forecast (2018-2025)
Figure Rest of South America Chondroitin Sulfate Market Forecast (2018-2025)
Figure Middle East and Africa Chondroitin Sulfate Market Forecast (2018-2025)
Figure Saudi Arabia Chondroitin Sulfate Market Forecast (2018-2025)
Figure United Arab Emirates Chondroitin Sulfate Market Forecast (2018-2025)
Figure Egypt Chondroitin Sulfate Market Forecast (2018-2025)
Figure Nigeria Chondroitin Sulfate Market Forecast (2018-2025)
Figure South Africa Chondroitin Sulfate Market Forecast (2018-2025)
Figure Turkey Chondroitin Sulfate Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Chondroitin Sulfate Market Forecast (2018-2025)
Figure Global Chondroitin Sulfate Forecast by Source (2018-2025)
Figure Global Chondroitin Sulfate Market Share Forecast by Source (2018-2025)
Figure Global Chondroitin Sulfate Forecast by Source (2018-2025)
Figure Global Chondroitin Sulfate Forecast by End User (2018-2025)
Figure Global Chondroitin Sulfate Market Share Forecast by End User (2018-2025)
Figure Global Chondroitin Sulfate Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*